A former CEO who built a cancer drugmaker for a decade and then joined Google's venture arm reveals 2 crucial elements he looks for when investing in startups

Business Insider – David Schenkein led Agios Pharmaceuticals from its early days in 2009 through the beginning of 2019. He joined Alphabet’s venture arm GV as a general partner in February, where he’s using his background running companies to back startups. When companies pitch Schenkein, he said there are two …

Read More »